Clinical Trials Directory

Trials / Completed

CompletedNCT05988970

Impact of Circadian Rhythm on the Spread of Circulating Tumor Cells in Lung Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Institut Claudius Regaud · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective pilot study designed to demonstrate the impact of circadian rhythm on the spread of Circulating Tumor Cells (CTCs) in patients with Non- Small Cell Lung Cancer - NSCLC. 27 patients will be included in the study and will be followed for 12 months. For each included patient, blood samples will be collected before the anticancer treatment initiation.

Conditions

Interventions

TypeNameDescription
OTHERBlood samples will be collected at two times before the treatment initiation:* at 4:00 a.m. * at 10:00 a.m. Patients will then be followed for data collection for a period of 12 months after inclusion or until disease progression (if applicable).

Timeline

Start date
2024-01-29
Primary completion
2026-01-21
Completion
2026-01-21
First posted
2023-08-14
Last updated
2026-01-27

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05988970. Inclusion in this directory is not an endorsement.

Impact of Circadian Rhythm on the Spread of Circulating Tumor Cells in Lung Cancer Patients (NCT05988970) · Clinical Trials Directory